Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,702 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
Tamura K, Matsuoka H, Tsukada J, Masuda M, Ikeda S, Matsuishi E, Kawano F, Izumi Y, Uike N, Utsunomiya A, Saburi Y, Shibuya T, Imamura Y, Hanada S, Okamura S, Gondoh H; Kyushu Hematology Organization for Treatment (K-HOT) Study Group. Tamura K, et al. Among authors: masuda m. Am J Hematol. 2002 Dec;71(4):248-55. doi: 10.1002/ajh.10236. Am J Hematol. 2002. PMID: 12447952 Free article. Clinical Trial.
Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
Mori M, Kitamura K, Masuda M, Hotta T, Miyazaki T, Miura AB, Mizoguchi H, Shibata A, Saito H, Matsuda T, Masaoka T, Harada M, Niho Y, Takaku F. Mori M, et al. Among authors: masuda m. Int J Hematol. 2005 Apr;81(3):246-54. doi: 10.1532/IJH97.03147. Int J Hematol. 2005. PMID: 15814336 Clinical Trial.
[A multicenter early phase II study of high-dose chemotherapy with autologous peripheral blood stem cell transplantation for treatment of intermediate-grade non-Hodgkin's lymphoma. Japan Blood Cell Transplantation Study Group].
Chou T, Ishiguro T, Imajo K, Kawano F, Gondo H, Kasai M, Masuda M, Koike M, Shimazaki C, Hara M, Shinagawa K, Ogawa M, Takaku F, Harada M. Chou T, et al. Among authors: masuda m. Rinsho Ketsueki. 1999 Oct;40(10):1058-67. Rinsho Ketsueki. 1999. PMID: 10565222 Clinical Trial. Japanese.
Clonal T cells of pure red-cell aplasia.
Masuda M, Teramura M, Matsuda A, Bessho M, Shimamoto T, Ohyashiki K, Omine M, Motoji T, Mizoguchi H. Masuda M, et al. Am J Hematol. 2005 Aug;79(4):332-3. doi: 10.1002/ajh.20374. Am J Hematol. 2005. PMID: 16044445 Free article.
Clinical features of polycythemia vera and essential thrombocythemia in Japan: retrospective analysis of a nationwide survey by the Japanese Elderly Leukemia and Lymphoma Study Group.
Dan K, Yamada T, Kimura Y, Usui N, Okamoto S, Sugihara T, Takai K, Masuda M, Mori M; Japanese Elderly Leukemia and Lymphoma Study Group. Dan K, et al. Among authors: masuda m. Int J Hematol. 2006 Jun;83(5):443-9. doi: 10.1532/IJH97.06009. Int J Hematol. 2006. PMID: 16787877
Switching to nilotinib is associated with deeper molecular responses in chronic myeloid leukemia chronic phase with major molecular responses to imatinib: STAT1 trial in Japan.
Noguchi S, Nakaseko C, Nishiwaki K, Ogasawara H, Ohishi K, Tokuhira M, Noguchi M, Kimura H, Handa H, Mitani K, Miura M, Wakita H, Takahashi N; STAT study group. Noguchi S, et al. Int J Hematol. 2018 Aug;108(2):176-183. doi: 10.1007/s12185-018-2459-6. Epub 2018 Apr 30. Int J Hematol. 2018. PMID: 29713954 Clinical Trial.
2,702 results